Rafferty Asset Management »

Summit Therapeutics shares owned by Rafferty Asset Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Rafferty Asset Management from 13F filings

Historical chart of Rafferty Asset Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Rafferty Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.7M 650k 4.14

More positions owned by Rafferty Asset Management

Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Advanced Micro Devices (AMD)
Apple (AAPL)
Qualcomm (QCOM)
Intel Corporation (INTC)
Micron Technology (MU)
Ishares Tr China Lg-cap Etf (FXI)
Texas Instruments Incorporated (TXN)
Applied Materials (AMAT)
Lam Research Corporation (LRCX)
Analog Devices (ADI)

View all positions for Rafferty Asset Management

Top funds holding Summit Therapeutics

BlackRock
FMR
Vanguard Group
Geode Capital Management
Northern Trust
Charles Schwab Investment Management
Morgan Stanley
Goldman Sachs Group
Rafferty Asset Management
Steward Partners Investment Advisory
Bank Of Montreal
Citigroup
ALPS Advisors
UBS Group
Barclays

View all funds holding Summit Therapeutics